Published mark

CervoMed Inc.

NASDAQ: CRVO. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc
SEC CIK
0001053691
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 6, 2026
Newest evidence
Apr 30, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
John AlamSince Apr 30, 2026
Chair
Not published
Independent
6 / 88 directors published
Published claims
263 distinct sources
Evidence records
90 pinned
Source conflicts
0None open

Built from 3 distinct sources and 9 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

CEO CHANGED

John Alam executive of CervoMed Inc., effective 2026-04-30.

EffectiveEffective Apr 30, 2026E3

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
President and Chief Executive OfficerJohn AlamApr 2026currentSource reportedE3
Executive Vice President, Clinical DevelopmentKelly BlackburnApr 2026currentSource reportedE4
Executive Vice President, Technical OperationsMarco VerwijsApr 2026currentSource reportedE5
Executive Vice President, Regulatory and Government Affairs and Program ManagementMark De RoschApr 2026currentSource reportedE6
Chief Commercial and Business OfficerMatthew WintonApr 2026currentSource reportedE7
Chief Financial Officer, General Counsel, Corporate SecretaryWilliam R. ElderApr 2026currentSource reportedE8

Board of directors

Evidence

8 directors published. 6 of 8 with a published determination are independent.

DirectorStatusSinceCommitteesClaim
Frank ZavrlIndependent2023AuditAudit; Compensation · Chair; Nominating and GovernanceCompensation, chairNominating and GovernanceSource reportedE2
Jane H. Hollingsworth, J.D.Independent2020None publishedSource reportedE2
Jeff PoultonIndependent2023Audit, chairAudit · Chair; CompensationCompensationSource reportedE2
John Alam, M.D.Not independent2023None publishedSource reportedE2
Joshua S. Boger, Ph.D.Independent2024None publishedSource reportedE2
Marwan Sabbagh, M.D.Independent2023None publishedSource reportedE2
Robert J. Cobuzzi, Jr., Ph.D.Not independent2023None publishedSource reportedE2
Sylvie Grégoire, PharmD.Independent2023None publishedSource reportedE2

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
AuditJeff PoultonJeff Poulton, Frank Zavrl, Jeff Poulton, Frank ZavrlNot described in the published record
Audit · Chair; CompensationNot publishedJeff PoultonNot described in the published record
Audit; Compensation · Chair; Nominating and GovernanceNot publishedFrank ZavrlNot described in the published record
CompensationFrank ZavrlFrank Zavrl, Jeff Poulton, Frank Zavrl, Jeff PoultonNot described in the published record
Nominating and GovernanceNot publishedFrank Zavrl, Frank ZavrlNot described in the published record
Committee RecordAudit: Chair Jeff Poulton; Members Jeff Poulton (Chair); Frank Zavrl
Source reportedE9
company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:committee_record:19
Committee AppointmentJeff Poulton: chair, Audit
Source reportedE9
company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:committee_appointment:20
Committee AppointmentFrank Zavrl: member, Audit
Source reportedE9
company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:committee_appointment:21
Committee RecordCompensation: Chair Frank Zavrl; Members Frank Zavrl (Chair); Jeff Poulton
Source reportedE9
company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:committee_record:22
Committee AppointmentFrank Zavrl: chair, Compensation
Source reportedE9
company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:committee_appointment:23
Committee AppointmentJeff Poulton: member, Compensation
Source reportedE9
company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:committee_appointment:24
Committee RecordNominating and Governance: Chair not stated; Members Frank Zavrl
Source reportedE9
company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:committee_record:25
Committee AppointmentFrank Zavrl: member, Nominating and Governance
Source reportedE9
company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:committee_appointment:26

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerJohn Alam, President and Chief Executive Officer, from Apr 30, 2026
Source reportedE3
company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:leadership_role:13
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingCRVO (NASDAQ)
Source reportedE1
company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:security_listing:27
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 6, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameCervoMed Inc.
Source reportedE1
company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc:entity_status:3

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
9 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 6, 2026. Cited by 4 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    CervoMed Inc. DEF 14A 2025-04-29
    sec proxy. Published Apr 29, 2025. Retrieved Apr 28, 2026. Cited by 8 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    CRVO DEF 14A executive officers
    sec filing. Published Apr 30, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    CRVO DEF 14A executive officers
    sec filing. Published Apr 30, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    CRVO DEF 14A executive officers
    sec filing. Published Apr 30, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    CRVO DEF 14A executive officers
    sec filing. Published Apr 30, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  7. E7
    CRVO DEF 14A executive officers
    sec filing. Published Apr 30, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  8. E8
    CRVO DEF 14A executive officers
    sec filing. Published Apr 30, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  9. E9
    Audit
    board_seats. board seats. Cited by 8 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 6, 2026
  • John Alam executive of CervoMed Inc., effective 2026-04-30.
  • Kelly Blackburn executive of CervoMed Inc., effective 2026-04-30.
  • Marco Verwijs executive of CervoMed Inc., effective 2026-04-30.
  • Mark De Rosch executive of CervoMed Inc., effective 2026-04-30.
  • Matthew Winton executive of CervoMed Inc., effective 2026-04-30.
  • William R. Elder executive of CervoMed Inc., effective 2026-04-30.
  • Joshua S. Boger, Ph.D. seat on CervoMed Inc., effective 2024-01-01.
  • Frank Zavrl seat on CervoMed Inc., effective 2023-01-01.
  • Jeff Poulton seat on CervoMed Inc., effective 2023-01-01.
  • John Alam, M.D. seat on CervoMed Inc., effective 2023-01-01.
  • Marwan Sabbagh, M.D. seat on CervoMed Inc., effective 2023-01-01.
  • Robert J. Cobuzzi, Jr., Ph.D. seat on CervoMed Inc., effective 2023-01-01.
  • Sylvie Grégoire, PharmD. seat on CervoMed Inc., effective 2023-01-01.
  • Audit · Chair; Compensation committee of CervoMed Inc., effective 2023-01-01.
  • Jeff Poulton member of Audit · Chair; Compensation, effective 2023-01-01.
  • Audit; Compensation · Chair; Nominating and Governance committee of CervoMed Inc., effective 2023-01-01.
  • Frank Zavrl member of Audit; Compensation · Chair; Nominating and Governance, effective 2023-01-01.
  • Jane H. Hollingsworth, J.D. seat on CervoMed Inc., effective 2020-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/cervomed-inc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership6
  4. Board8
  5. Committees5
  6. Control and voting0
  7. Authority to act4
  8. Financials1
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims3
  15. Coverage gaps17
  16. Linked people14
  17. Subject and corrections6
  18. Evidence9
  19. Version historyvpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc
  • Cite this recordCervoMed Inc.
  • Copy canonical URLregistry.alpha.ac/companies/cervomed-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    CervoMed Inc.Company
  • John AlamPerson
  • Kelly BlackburnPerson
  • Marco VerwijsPerson
  • Mark De RoschPerson
  • Matthew WintonPerson
  • William R. ElderPerson
  • Frank ZavrlPerson
  • Jane H. Hollingsworth, J.D.Person
  • Jeff PoultonPerson
  • John Alam, M.D.Person
  • Joshua S. Boger, Ph.D.Person
  • Marwan Sabbagh, M.D.Person
  • Robert J. Cobuzzi, Jr., Ph.D.Person
  • Sylvie Grégoire, PharmD.Person
  • Sections
    OverviewCervoMed Inc.
  • MonitoringCervoMed Inc.
  • LeadershipCervoMed Inc.
  • BoardCervoMed Inc.
  • CommitteesCervoMed Inc.
  • Control and votingCervoMed Inc.
  • Authority to actCervoMed Inc.
  • FinancialsCervoMed Inc.
  • GovernanceCervoMed Inc.
  • RiskCervoMed Inc.
  • AI oversightCervoMed Inc.
  • LegalCervoMed Inc.
  • CompensationCervoMed Inc.
  • Other published claimsCervoMed Inc.
  • Coverage gapsCervoMed Inc.
  • Linked peopleCervoMed Inc.
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.